AXXZIA Inc. (TYO:4936)
Japan
· Delayed Price · Currency is JPY 363.00
+6.00 (1.68%)
Mar 10, 2026, 2:04 PM JST
AXXZIA Revenue
AXXZIA had revenue of 3.63B JPY in the quarter ending October 31, 2025, with 17.92% growth. This brings the company's revenue in the last twelve months to 14.03B, up 11.89% year-over-year. In the fiscal year ending July 31, 2025, AXXZIA had annual revenue of 13.48B with 10.55% growth.
Revenue (ttm)
14.03B
Revenue Growth
+11.89%
P/S Ratio
0.58
Revenue / Employee
56.58M
Employees
248
Market Cap
8.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 13.48B | 1.29B | 10.55% |
| Jul 31, 2024 | 12.19B | 851.00M | 7.50% |
| Jul 31, 2023 | 11.34B | 3.13B | 38.05% |
| Jul 31, 2022 | 8.22B | 2.43B | 41.96% |
| Jul 31, 2021 | 5.79B | 1.50B | 34.90% |
| Jul 31, 2020 | Pro | Pro | Pro |
| Jul 31, 2019 | Pro | Pro | Pro |
| Jul 31, 2018 | Pro | Pro | Pro |
| Jul 31, 2017 | Pro | Pro | Pro |
| Jul 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Almado | 10.18B |
| Sagami Rubber Industries | 5.79B |
| HABA Laboratories,Inc. | 12.17B |
| Liberta | 10.03B |
| Adjuvant Holdings | 3.97B |
| Premier Anti-Aging | 15.57B |
| C'BON COSMETICS | 9.22B |
| Niitaka | 24.16B |